Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1995-1-5
|
| pubmed:abstractText |
Surgical exploration for gastrinoma has a high failure rate because of small primary tumors and occult metastasis. Despite extensive preoperative and intraoperative tumor localization, only 30% to 40% of patients with gastrinoma are cured by surgery. Two patients with unlocalized gastrinomas were studied with intraoperative gamma detection of an iodine 125-labeled somatostatin analog, lanreotide, to localize their tumors.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0039-6060
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
116
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1139-46; discussion 1146-7
|
| pubmed:dateRevised |
2010-3-24
|
| pubmed:meshHeading |
pubmed-meshheading:7985099-Adult,
pubmed-meshheading:7985099-Female,
pubmed-meshheading:7985099-Gastrinoma,
pubmed-meshheading:7985099-Humans,
pubmed-meshheading:7985099-Iodine Radioisotopes,
pubmed-meshheading:7985099-Male,
pubmed-meshheading:7985099-Pancreatic Neoplasms,
pubmed-meshheading:7985099-Peptides, Cyclic,
pubmed-meshheading:7985099-Somatostatin
|
| pubmed:year |
1994
|
| pubmed:articleTitle |
Detection of occult gastrinomas with iodine 125-labeled lanreotide and intraoperative gamma detection.
|
| pubmed:affiliation |
Department of Surgery, Louisiana State University, New Orleans.
|
| pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|